NBIX Stock Signals: 29 Detections Since 2012
JumpstartSignal's 5-stage screening system flagged Neurocrine Biosciences (NBIX) on 29 individual trading days (6 signal clusters) across our 14-year backtest (2012–2025). Best signal: +1430% from Mar 19, 2012 vs +521% SPY over the same period.
(vs +521% SPY)
6/6 clusters
6 clusters
per signal
About Neurocrine Biosciences
Neurocrine Biosciences develops drugs for neurological and endocrine disorders. Its lead product INGREZZA (valbenazine) — approved in 2017 for tardive dyskinesia — became a blockbuster through strong physician adoption and market exclusivity, providing the recurring product revenue that funded a diversifying late-stage pipeline across CNS and endocrine indications.
NBIX Signal History (2012–2019)
Each row represents one signal cluster — when consecutive daily signals appeared they are grouped together. Entry price shown is the best entry within each cluster. Returns measured to 2026-02-01.
| Signal Date | Entry Price | Return | Price (Feb '26) | SPY (same period) | Alpha |
|---|---|---|---|---|---|
| Mar 19, 2012 3-day | $8.89 | +1430% | $136.06 | +521% | +910% |
| Feb 21, 2013 9-day | $10.55 | +1190% | $136.06 | +477% | +713% |
| Apr 1, 2013 8-day | $11.77 | +1056% | $136.06 | +446% | +610% |
| Sep 3, 2013 3-day | $15.64 | +770% | $136.05 | +418% | +352% |
| Jan 24, 2018 | $88.73 | +53% | $136.02 | +174% | -121% |
| Oct 22, 2019 5-day | $97.70 | +39% | $136.10 | +147% | -108% |
NBIX Return vs SPY — per signal cluster
Past performance does not indicate future results. Returns calculated from each signal's entry date to 2026-02-01. Consecutive daily signals within 14 days are grouped as one cluster; best entry price within the cluster is shown. Data sourced from JumpstartSignal's 14-year backtest using historical prices.
How JumpstartSignal Screened NBIX
Each NBIX signal above passed through all five stages:
Stage 3 scores quality signals — ROE, low debt, MA stack (0–60 pts) — and entry timing signals — golden cross, breakout volume, VWAP momentum (0–20 pts). Stage 4 adds AI news sentiment (0–10 pts) and a sector bonus (0–10 pts) for a combined score out of 100. NBIX reached ✅ OPPORTUNITY status (score ≥70) — appearing in the daily watchlist alongside 🏆 SPOTLIGHT (≥73) signals.
Full methodology →Get signals like these delivered daily
When stocks pass all 5 stages of our screening system, the signal lands in your inbox each trading day.
No spam. Unsubscribe in one click.